Article
Immunoscreening of the extracellular proteome of colorectal cancer cells
25 Feb 2010
Abstract excerpt
BACKGROUND: The release of proteins from tumors can trigger an immune response in cancer patients involving T lymphocytes and B lymphocytes, which results in the generation of antibodies to tumor-derived proteins. Many studies aim to use humoral immune responses, namely autoantibody profiles, directly, as clinical biomarkers. Alternatively, the antibody immune response as an amplification system for tumor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
